Intra-ImmuSG Pte Ltd
🇸🇬Singapore
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients with Solid Tumors
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Intra-IMMUSG Pte Ltd
- Target Recruit Count
- 51
- Registration Number
- NCT04452955
- Locations
- 🇺🇸
HonorHealth Research, Scottsdale, Arizona, United States
🇺🇸St. Jude Medical Center, Fullerton, California, United States
🇺🇸The Angeles Clinic, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath